Grifols (GIFLF) FCF Margin (2010 - 2020)
Grifols' (GIFLF) quarterly FCF Margin came in at 8.15% in Q1 2020, up 2265.0% on a YoY basis from 0.34% in Q2 2019, and down 10.23% quarter-over-quarter from 9.08% in Q4 2019.
Analysis
Grifols (GIFLF) FCF Margin (2010 - 2020) Analysis & Trends
Grifols (GIFLF) has reported FCF Margin for 11 consecutive years, with 8.15% the latest figure, recorded in Q1 2020.
- For the quarter ending Q1 2020, FCF Margin rose 2265.0% year-over-year to 8.15%; the trailing twelve-month figure through Mar 2020 stood at 7.24% (down 27.0% YoY), and the FY2025 full-year result was 10.39%, down 33643.0% from the prior year.
- FCF Margin fell to 8.15% in Q1 2020 per GIFLF's latest filing, from 9.08% in the prior quarter.
- Across five years, FCF Margin topped out at 20.62% in Q2 2017 and bottomed at 14.5% in Q1 2019.
- Historically, FCF Margin has averaged 10.94% across 5 years, with a median of 12.52% in 2018.
- The sharpest annual moves came in 2019 and 2020: FCF Margin sank 2356 bps in 2019, then jumped 2265 bps in 2020.
- Over 5 years, FCF Margin stood at 9.24% in 2016, then jumped by 90 bps to 17.56% in 2017, then dropped by 29 bps to 12.52% in 2018, then slipped by 28 bps to 9.08% in 2019, then decreased by 10 bps to 8.15% in 2020.
- According to Business Quant data, FCF Margin over the past three periods registered 8.15%, 9.08%, and 14.5% for Q1 2020, Q4 2019, and Q1 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -18,629.40% |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 8.15% |
| Dec 31, 2019 | 9.08% |
| Mar 31, 2019 | -14.50% |
| Dec 31, 2018 | 12.52% |
| Jun 30, 2018 | 14.26% |
| Mar 31, 2018 | 9.06% |
| Dec 31, 2017 | 17.56% |
| Jun 30, 2017 | 20.62% |
| Mar 31, 2017 | 13.69% |
| Dec 31, 2016 | 9.24% |
| Sep 30, 2016 | 20.60% |
| Dec 31, 2015 | 29.20% |
| Sep 30, 2015 | 18.04% |
| Jun 30, 2015 | 22.48% |
| Mar 31, 2015 | 3.76% |
| Dec 31, 2014 | 13.25% |
| Sep 30, 2014 | 79.23% |
| Jun 30, 2014 | -15,313.64% |
| Mar 31, 2014 | 15.65% |
| Dec 31, 2013 | 1,398.84% |